“A Word to the Wise About Ketamine”


Commentary in the American Journal of Psychiatry cautions that the “unbridled enthusiasm” about Ketamine as a “miracle cure” for depression “needs to be tempered by a more rational and guarded perspective,” noting that the drug is already being administered off-label in private psychiatry clinics without regulation by the FDA.

Article →

Schatzberg, A., A Word to the Wise About Ketamine. American Journal of Psychiatry. March 1, 2014. 171: 262-264. doi:10.1176/appi.ajp.2014.13101434

Of further interest:
Warning about Ketamine in the American Journal of Psychiatry (The Neurocritic)

Previous article“Erasing History”: 1BoringOldMan on Psychiatry’s Scramble to Re-Brand Itself
Next articleDSM-5 And Somatic Symptom Disorder
Kermit Cole
Kermit Cole, MFT, founding editor of Mad in America, works in Santa Fe, New Mexico as a couples and family therapist. Inspired by Open Dialogue, he works as part of a team and consults with couples and families that have members identified as patients. His work in residential treatment — largely with severely traumatized and/or "psychotic" clients — led to an appreciation of the power and beauty of systemic philosophy and practice, as the alternative to the prevailing focus on individual pathology. A former film-maker, he has undergraduate and master's degrees in psychology from Harvard University, as well as an MFT degree from the Council for Relationships in Philadelphia. He is a doctoral candidate with the Taos Institute and the Free University of Brussels. You can reach him at [email protected].